詳情請(qǐng)點(diǎn)擊：葉黃素就選今馨爾

Avedro is a privately held pharmaceutical and medical device company advancing the science and technology of corneal cross-linking and refractive correction.

Our mission is to produce and deliver innovative, minimally invasive, drugs and devices for corneal remodeling to eye care professionals around the world to improve patients’ vision and quality of life. Avedro’s talented and motivated employees deliver premium, differentiated, high quality products and experiences in order to delight our customers, establish and maintain ourselves as the market leader and increase our enterprise value.

Avedro’s products sold outside of the United States include capital equipment such as the UV-X devices, the KXL and Mosaic? Systems, and related proprietary pharmaceuticals such as the VibeX? and MedioCROSS? formulations. Avedro distributes its products in countries outside of the United States through a network of ophthalmic medical device distributors.
 

部分翻譯僅供參考：

Avedro是一家私營(yíng)的醫(yī)藥和醫(yī)療器械公司，致力于推動(dòng)角膜交聯(lián)和屈光矯正的科學(xué)和技術(shù)。
我們的使命是為世界各地的眼科護(hù)理專家生產(chǎn)和提供創(chuàng)新的、微創(chuàng)的、用于角膜重塑的藥物和設(shè)備，以改善患者的視力和生活質(zhì)量。Avedro富有才華、積極進(jìn)取的員工為客戶提供優(yōu)質(zhì)、差異化、高品質(zhì)的產(chǎn)品和體驗(yàn)，以滿足客戶的需求，樹(shù)立并保持市場(chǎng)領(lǐng)先地位，提升企業(yè)價(jià)值。

      

公司網(wǎng)址 http://avedro.com/

相關(guān)報(bào)道：中國(guó)藥監(jiān)局核準(zhǔn)Avedro的KXL系統(tǒng)

（更新時(shí)間：2023-8-7 SONG CHENG cheng）